HRAS and head and neck squamous cell carcinoma: In HNSCC, HRAS is mutated in approximately 4–8% of patients; among these patients, there is a subset of HPV-negative patients without p53 or caspase-8 mutations and with alterations in DNA copy number (low chromosomal instability) [65].